MicroRNA-612 regulates the proliferation and epithelial-to-mesenchymal transition of human colon cancer cells via G protein-coupled receptor 132 (GPR132)

Purpose: To investigate the effect of microRNA-612 (miR-612) on human colon cancer cells, and the mechanism involved. Methods: Expressions of miR-612 and GPR132 were determined by quantitative real-time polymerase chain reaction (qRT-PCR)el , while cell viability was evaluated using cell counting kit-8 (CCK8) and colony formation assays. Dual luciferase assay was used to determine the interaction between miR-612 and GPR132, while cell migration and invasion were measured by Transwell assay. Results: The expression levels of miR-612 in colon cancer tissues and cell lines were significantly down-regulated (p < 0.05). Overexpression of miR-612 in colon cancer cells led to significant inhibition of their proliferation and colony formation. Transwell assays revealed that miR-612 overexpression markedly stopped the migration, invasion and epithelial-to-mesenchymal transition. Conclusion: These results indicate that miR-612 exerts anti-cancer effect by suppressing the expression of GPR132 at the translational level. The in vitro tumor suppressive activity of miR-612 against colon cancer reveals its potential for the management of colon cancer.

[1]  S. Karmakar,et al.  Exploring the Role of Gut Microbiome in Colon Cancer , 2021, Applied Biochemistry and Biotechnology.

[2]  Q. Jiang,et al.  Low miR-1273a expression predicts poor prognosis of colon cancer and facilitates tumor cell proliferation, migration, and invasion , 2021, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[3]  D. Ribatti,et al.  Epithelial-Mesenchymal Transition in Cancer: A Historical Overview , 2020, Translational oncology.

[4]  H. Kenar,et al.  Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling. , 2020, Omics : a journal of integrative biology.

[5]  Y. Lv,et al.  Identifying a new microRNA signature as a prognostic biomarker in colon cancer , 2020, PloS one.

[6]  M. Cui,et al.  MicroRNA‐612 inhibits cervical cancer progression by targeting NOB1 , 2020, Journal of cellular and molecular medicine.

[7]  K. Skrzypek,et al.  Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis. , 2019, Acta biochimica Polonica.

[8]  V. De Maertelaer,et al.  Context Dependency of Epithelial-to-Mesenchymal Transition for Metastasis. , 2019, Cell reports.

[9]  Qingliang Wang,et al.  Long non-coding RNA LINC00460 promotes head and neck squamous cell carcinoma cell progression by sponging miR-612 to up-regulate AKT2. , 2019, American journal of translational research.

[10]  A. Singh,et al.  Emerging Role of Migration and Invasion Enhancer 1 (MIEN1) in Cancer Progression and Metastasis , 2019, Front. Oncol..

[11]  Z. Culig.  Epithelial mesenchymal transition and resistance in endocrine-related cancers. , 2019, Biochimica et biophysica acta. Molecular cell research.

[12]  J. Shih,et al.  MicroRNA in Lung Cancer Metastasis , 2019, Cancers.

[13]  Ahmed M. Kabel,et al.  Colorectal Cancer: New Perspectives , 2018 .

[14]  N. Hall,et al.  Colorectal Cancer:: Imaging Conundrums. , 2018, Surgical oncology clinics of North America.

[15]  L. Roncucci,et al.  Prevention of colorectal cancer: How many tools do we have in our basket? , 2015, European journal of internal medicine.

[16]  K. Okamura,et al.  Regulatory RNAs discovered in unexpected places , 2015, Wiley interdisciplinary reviews. RNA.

[17]  P. He,et al.  miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2 , 2015, Cell Death and Disease.

[18]  K. Safranow,et al.  Molecular Basis of Human CD36 Gene Mutations , 2007, Molecular medicine.

[19]  Frank J. Slack,et al.  The Role of MicroRNAs in Cancer , 2006, The Yale journal of biology and medicine.